Try our clinical trial finder
Getting started with the Colorectal Cancer Alliance Clinical Trial Finder is easy! Answering a simple series of questions allows us to find relevant trials that fit your needs.
Let's get started
After completing the questions below, you will be presented with your personalized results.
If no trials are available, then our system will continue to search and alert you if a match is made.
Up Next
More about clinical trialsTop resources
Treatment for KRAS G12C-mutated metastatic CRC approved by FDA
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.
Watch session videos from AllyCon 2024
Watch videos of two major general sessions from AllyCon 2024, the Alliance's patient support conference, which took place in Miami Beach in December.
Krazati approved for previously treated KRASG12C colorectal cancer
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.